Ask AI
Managing Tardive Dyskinesia in Long-term Care

CE / CME

Identification and Management of Tardive Dyskinesia: Best Practices to Promote Real-world Practice Change in the Long-term Care Setting

Physician Assistants/Physician Associates: 0.75 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.75 Nursing contact hour

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

Released: September 18, 2024

Expiration: September 17, 2025

Pretest

Progress
1 2
Course Completed
1.

How knowledgeable do you feel regarding the safety profile of VMAT2 inhibitors in older patients?

2.

The gold standard for assessing and monitoring TD is:

3.

Which adverse events are most frequently seen with VMAT2 inhibitor treatment?

4.

A patient currently treated with a second-generation antipsychotic has developed noticeable symptoms of TD. Which VMAT2 inhibitor(s) is/are FDA approved to treat his condition?